125 related articles for article (PubMed ID: 15608583)
21. Surveillance of antibiotic resistance of Neisseria gonorrhoeae isolates in China, 1993-1998.
Ye S; Su X; Wang Q; Yin Y; Dai X; Sun H
Sex Transm Dis; 2002 Apr; 29(4):242-5. PubMed ID: 11912467
[TBL] [Abstract][Full Text] [Related]
22. [Ciprofloxacin resistance of Neisseria gonorrhoeae according to sexual habits].
García S; Casco R; Perazzi B; De Mier C; Vay C; Famiglietti A
Medicina (B Aires); 2008; 68(5):358-62. PubMed ID: 18977704
[TBL] [Abstract][Full Text] [Related]
23. Molecular epidemiology of recently emergent ciprofloxacin-resistant Neisseria gonorrhoeae in South Africa.
Moodley P; Martin IM; Pillay K; Ison CA; Sturm AW
Sex Transm Dis; 2006 Jun; 33(6):357-60. PubMed ID: 16572037
[TBL] [Abstract][Full Text] [Related]
24. Ciprofloxacin resistance in Neisseria gonorrhoeae: trends in Hawaii, 1997-2002.
Katz AR; Lee MV; Ohye RG; Whiticar PM; Effler PV
Lancet; 2003 Aug; 362(9382):495. PubMed ID: 12927447
[No Abstract] [Full Text] [Related]
25. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
[TBL] [Abstract][Full Text] [Related]
26. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
[TBL] [Abstract][Full Text] [Related]
27. Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States.
Goldstein E; Kirkcaldy RD; Reshef D; Berman S; Weinstock H; Sabeti P; Del Rio C; Hall G; Hook EW; Lipsitch M
Emerg Infect Dis; 2012 Aug; 18(8):1290-7. PubMed ID: 22840274
[TBL] [Abstract][Full Text] [Related]
28. Increasing resistance of Neisseria gonorrhoeae in west and central Africa. Consequence on therapy of gonococcal infection.
Van Dyck E; Crabbé F; Nzila N; Bogaerts J; Munyabikali JP; Ghys P; Diallo M; Laga M
Sex Transm Dis; 1997 Jan; 24(1):32-7. PubMed ID: 9018781
[TBL] [Abstract][Full Text] [Related]
29. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1994 May; 43(18):325-7. PubMed ID: 8164636
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003.
Bauer HM; Mark KE; Samuel M; Wang SA; Weismuller P; Moore D; Gunn RA; Peter C; Vannier A; DeAugustine N; Klausner JD; Knapp JS; Bolan G
Clin Infect Dis; 2005 Sep; 41(6):795-803. PubMed ID: 16107976
[TBL] [Abstract][Full Text] [Related]
31. Activity of gemifloxacin tested against Neisseria gonorrhoeae isolates including antimicrobial-resistant phenotypes.
Pottumarthy S; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):127-34. PubMed ID: 16423492
[TBL] [Abstract][Full Text] [Related]
32. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009.
Martin I; Jayaraman G; Wong T; Liu G; Gilmour M;
Sex Transm Dis; 2011 Oct; 38(10):892-8. PubMed ID: 21934558
[TBL] [Abstract][Full Text] [Related]
33. Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998.
Dillon JA; Rubabaza JP; Benzaken AS; Sardinha JC; Li H; Bandeira MG; dos Santos Fernando Filho E
Sex Transm Dis; 2001 Sep; 28(9):521-6. PubMed ID: 11518869
[TBL] [Abstract][Full Text] [Related]
34. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
Shigemura K; Shirakawa T; Okada H; Hinata N; Acharya B; Kinoshita S; Kofuku T; Kawabata M; Kamidono S; Arakawa S; Gotoh A
Sex Transm Dis; 2004 Mar; 31(3):180-4. PubMed ID: 15076932
[TBL] [Abstract][Full Text] [Related]
35. Ciprofloxacin resistance emerges in Neisseria gonorrhoeae in Victoria, 1998 to 2001.
Veitch MG; Griffith JM; Morgan ML
Commun Dis Intell Q Rep; 2003; 27 Suppl():S75-9. PubMed ID: 12807279
[TBL] [Abstract][Full Text] [Related]
36. Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
Jones RN; Critchley IA; Whittington WL; Janjic N; Pottumarthy S
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):311-7. PubMed ID: 16269221
[TBL] [Abstract][Full Text] [Related]
37. Multiclonal increase in ciprofloxacin-resistant Neisseria gonorrhoeae, Thailand, 1998-1999.
Trees DL; Sirivongrangson P; Schultz AJ; Buatiang A; Neal SW; Knapp JS; Kilmarx PH
Sex Transm Dis; 2002 Nov; 29(11):668-73. PubMed ID: 12438903
[TBL] [Abstract][Full Text] [Related]
38. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.
Wang SA; Lee MV; O'Connor N; Iverson CJ; Ohye RG; Whiticar PM; Hale JA; Trees DL; Knapp JS; Effler PV; Weinstock HS
Clin Infect Dis; 2003 Sep; 37(6):849-52. PubMed ID: 12955650
[TBL] [Abstract][Full Text] [Related]
39. Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006.
Lee H; Hong SG; Soe Y; Yong D; Jeong SH; Lee K; Chong Y
Sex Transm Dis; 2011 Nov; 38(11):1082-6. PubMed ID: 21992988
[TBL] [Abstract][Full Text] [Related]
40. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Apr; 56(14):332-6. PubMed ID: 17431378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
